| Literature DB >> 16828551 |
Stephan Schann1, Christel Menet, Paul Arvault, Géraldine Mercier, Mélanie Frauli, Stanislas Mayer, Nadia Hubert, Nicolas Triballeau, Hugues-Olivier Bertrand, Francine Acher, Pascal Neuville.
Abstract
A new family of mGlu receptor orthosteric ligands called APTCs was designed and synthesized using a parallel chemistry approach. Amongst 65 molecules tested on mGlu4, mGlu6 and mGlu8 subtypes, (2S,4S)-4-amino-1-[(E)-3-carboxyacryloyl]pyrrolidine-2,4-dicarboxylic acid (8a06-FP0429) has been shown to be a full mGlu4 agonist and a partial mGlu8 agonist. In addition, 8a06 was shown to be selective versus group I and II mGlu subtypes. A possible explanation for this efficacy difference is proposed by docking experiment performed with molecular model of the receptor.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16828551 DOI: 10.1016/j.bmcl.2006.06.062
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823